Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

NCT01040091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Emtricitabine (FTC)
DRUG: Tenofovir disoproxil fumarate (TDF)
DRUG: Efavirenz (EFV)
DRUG: Truvada

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)